SCHEMBL13635157

SCHEMBL13635157

CC(=O)NCCCC[C@H](NC(C)=O)C(N)=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT5 Q9NXA8 3/20 0.65
ALB P02768 3/20 0.55
SIRT6 Q8N6T7 1/20 0.54
SIRT1 Q96EB6 1/20 0.54
FOLH1 Q04609 1/20 0.53
KDM4E B2RXH2 1/20 0.52
MAPK1 P28482 1/20 0.52
HIF1A Q16665 1/20 0.52
PAOX Q6QHF9 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.44
ADRA1A P35348 1/20 0.43
PTPN2 P17706 2/20 0.43
PTPN1 P18031 2/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM1 P11229 1/20 0.42
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
GNPAT O15228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311708 1.00 SIRT5 (0.65) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL18461328 0.91 ALB (0.65) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL11887166 0.89 KDM4E (0.56) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL10408291 0.89 KDM4E (0.56) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL13446714 0.88 SIRT5 (0.54) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL16285431 0.87 SIRT5 (0.53) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL10130532 0.87 SIRT5 (0.60) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL20414861 0.86 KDM4E (0.52) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL20411608 0.86 KDM4E (0.52) SIRT5ALBSIRT6SIRT1FOLH1
SCHEMBL8106503 0.86 KDM4E (0.52) SIRT5ALBSIRT6SIRT1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022272154-A2 SMALL MOLECULE COMPOUNDS APERTOR PHARMACEUTICALS, INC. (US) 2022-12-29 WO disclosed
US-20130244939-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2013-09-19 US disclosed
US-20130130979-A1 PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2013-05-23 US disclosed
US-8304391-B2 Peptides that bind to the erythropoietin receptor AFFYMAX, INC. (US) 2012-11-06 US disclosed
US-20090227508-A1 PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2009-09-10 US disclosed
US-7528104-B2 Peptides that bind to the erythropoietin receptor AFFYMAX, INC. (US) 2009-05-05 US disclosed
US-20070027074-A1 Novel peptides that bind to the erythropoietin receptor AFFYMAX, INC. (US) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130244939-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR EPOR, PROKR1, EDNRB SIRT5 3853/4885ALB 1115/4885SIRT6 3745/4885
US-20090227508-A1 PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR EPOR, PROKR1, EDNRB SIRT5 3689/4885ALB 1060/4885SIRT6 3735/4885
US-20130130979-A1 PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR EPOR, PROKR1, EDNRB SIRT5 3689/4885ALB 1060/4885SIRT6 3735/4885
US-20070027074-A1 Novel peptides that bind to the erythropoietin receptor EPOR, PROKR1, EDNRB SIRT5 3853/4885ALB 1115/4885SIRT6 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.